台灣細胞治療的可行方案

A Path Forward in Taiwan Cell Therapy

隨著再生醫療在全球持續推進，台灣也同步發展相關政策、法規及技術。最近的研究強調了細胞療法在治療或治癒各種難治性疾病方面的潛力。在強大的監管框架、開創性研究和臨床卓越的支持下，台灣在細胞治療領域正在顯著的成長。本文探討細胞治療的最新發展，包括免疫細胞治療及幹細胞治療，以及台灣臨床應用的現況。強調了醫檢師在確保細胞治療產品的品質和安全方面的關鍵角色。未來的發展方向包括個人化醫療、國際合作以及擴大治療應用到自體免疫和神經系統疾病等領域。儘管存在法規保守、成本高昂以及需要標準化協議等挑戰，進一步整合人工智慧和大數據分析等數位技術將促進細胞治療的進步。透過持續的法規調整與技術創新，台灣可望成為細胞治療領域的全球領導者。

As regenerative medicine continues to advance around the world, Taiwan is concurrently developing relevant policies, regulations, and technologies. Recent studies have highlighted the potential of cell therapy in treating or curing various intractable diseases. Taiwan is experiencing significant growth in the field of cell therapy, supported by robust regulatory frameworks, pioneering research, and clinical excellence. This article explores the latest developments in cell therapy, including immune cell therapy and stem cell therapy, as well as the current status of clinical applications in Taiwan. The critical role of medical technologists (MTs) in ensuring the quality and safety of cell therapy products is emphasized. Future directions for development include personalized medicine, international collaboration, and expanding therapeutic applications to areas such as autoimmune and neurological diseases. Despite challenges such as conservative regulations, high costs, and the need for standardized protocols, the further integration of digital technologies, such as artificial intelligence and big data analysis, will promote the advancement of cell therapy. Through continuous regulatory adjustments and technological innovation, Taiwan is poised to become a global leader in cell therapy.